was awarded the Jeremy Jass Prize (2014), Stand up to Cancer Translational Cancer Research Prize (2015), Glaxo Smithkline Biochemical Society Prize in recognition of distinguished research leading to new advances in medical science and the Ellison-Cliffe Medal and Lecture, Royal Society of Medicine (2016). Charles was appointed Napier Professor in Cancer by the Royal Society in 2016.

Trever Bivona

Title: Speaker

Country: USA

Organisation: Helen Diller Family Comprehensive Cancer Centre

Trever completed his MD and PhD at NYU School of Medicine, before moving to the Brigham and Women’s Hospital/Harvard and then Memorial Sloan Kettering Cancer Centre for advanced training. He’s now based at the University of California at San Francisco, Helen Diller Family Comprehensive Cancer Centre, where he is an Associate Professor, and has been since 2011.

The goal of his research is tothe CRUK Lincoln’s Inn Fields Institute with Fiona Watt working on integrin adhesion molecules and cancer cell survival. He then moved as an MRC Clinician Scientist to UCL leading a group interested in the role of stem cells in lung cancer pathogenesis and treatment of lung disease using cell therapies. He was awarded a Wellcome Trust Senior Clinical Fellowship in October 2010 to work on novel cell therapies for lung cancers resulting in a DPFS first–in–man award and recently won his Wellcome Senior Fellowship renewal to study lung cancer pathogenesis.

He works as a consultant at UCLH with a particular interest in Lung Cancer, mesothelioma, interventional and diagnostic bronchoscopy and early lung cancer detection. He is Head of Respiratory Research Department at UCL and director of the Lung Cancer